Prosight Management as of June 30, 2020
Portfolio Holdings for Prosight Management
Prosight Management holds 52 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Put Put Option | 12.0 | $28M | 195k | 143.18 | |
| Arena Pharmaceuticals Com New | 6.1 | $14M | 227k | 62.95 | |
| Reata Pharmaceuticals Cl A | 5.5 | $13M | 82k | 156.02 | |
| Kura Oncology (KURA) | 4.8 | $11M | 685k | 16.30 | |
| Centene Corporation (CNC) | 4.4 | $10M | 160k | 63.55 | |
| Alexion Pharmaceuticals | 4.3 | $10M | 90k | 112.24 | |
| Change Healthcare | 4.0 | $9.3M | 830k | 11.20 | |
| Zimmer Holdings (ZBH) | 3.5 | $8.2M | 69k | 119.36 | |
| Ac Immune Sa SHS (ACIU) | 3.4 | $7.9M | 1.2M | 6.73 | |
| Cue Biopharma (CUE) | 3.3 | $7.6M | 310k | 24.51 | |
| Cigna Corp (CI) | 3.1 | $7.2M | 39k | 187.66 | |
| Bristol Myers Squibb (BMY) | 3.0 | $6.9M | 118k | 58.80 | |
| Aldeyra Therapeutics (ALDX) | 2.9 | $6.8M | 1.6M | 4.17 | |
| Meiragtx Holdings (MGTX) | 2.8 | $6.5M | 520k | 12.52 | |
| Uniqure Nv SHS (QURE) | 2.8 | $6.4M | 143k | 45.06 | |
| Iovance Biotherapeutics (IOVA) | 2.5 | $5.9M | 215k | 27.45 | |
| Albireo Pharma | 2.3 | $5.3M | 199k | 26.49 | |
| Aptose Biosciences Com New | 2.1 | $4.9M | 783k | 6.31 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.1 | $4.9M | 114k | 43.19 | |
| Cellectis S A Spon Ads (CLLS) | 2.1 | $4.9M | 277k | 17.80 | |
| Zogenix Com New | 1.7 | $4.0M | 146k | 27.01 | |
| Adma Biologics (ADMA) | 1.6 | $3.8M | 1.3M | 2.93 | |
| Baxter International (BAX) | 1.6 | $3.7M | 43k | 86.09 | |
| Bristol-myers Squibb Call Call Option | 1.3 | $2.9M | 50k | 58.80 | |
| Vericel (VCEL) | 1.2 | $2.9M | 210k | 13.82 | |
| Pacira Pharmaceuticals (PCRX) | 1.2 | $2.9M | 55k | 52.47 | |
| Personalis Ord (PSNL) | 1.1 | $2.4M | 189k | 12.97 | |
| Establishment Labs Holdings Ord (ESTA) | 1.0 | $2.4M | 127k | 18.68 | |
| Immunovant (IMVT) | 1.0 | $2.3M | 96k | 24.35 | |
| Organogenesis Hldgs (ORGO) | 0.9 | $2.1M | 536k | 3.84 | |
| Encompass Health Corp (EHC) | 0.9 | $2.0M | 33k | 61.91 | |
| United Therapeutics Corporation (UTHR) | 0.8 | $1.8M | 15k | 121.00 | |
| Turning Point Therapeutics I | 0.7 | $1.7M | 26k | 64.60 | |
| Translate Bio | 0.7 | $1.6M | 90k | 17.92 | |
| Aurinia Pharmaceuticals (AUPH) | 0.6 | $1.5M | 92k | 16.25 | |
| Evolus (EOLS) | 0.6 | $1.5M | 282k | 5.30 | |
| Cara Therapeutics (CARA) | 0.6 | $1.5M | 87k | 17.10 | |
| Catalyst Biosciences Com New | 0.6 | $1.5M | 248k | 5.87 | |
| Magenta Therapeutics | 0.5 | $1.3M | 169k | 7.51 | |
| AMN Healthcare Services (AMN) | 0.5 | $1.2M | 27k | 45.25 | |
| Neogenomics Com New (NEO) | 0.5 | $1.2M | 39k | 30.99 | |
| Providence Service Corporation | 0.5 | $1.2M | 15k | 78.94 | |
| Evofem Biosciences | 0.5 | $1.2M | 413k | 2.83 | |
| Biotelemetry | 0.5 | $1.1M | 25k | 45.20 | |
| Xeris Pharmaceuticals | 0.5 | $1.1M | 420k | 2.66 | |
| LHC | 0.3 | $786k | 4.5k | 174.32 | |
| Apollo Endosurgery | 0.3 | $621k | 380k | 1.63 | |
| Stealth Biotherapeutics Corp Sponsored Ads | 0.2 | $533k | 291k | 1.83 | |
| Magellan Health Com New | 0.2 | $379k | 5.2k | 72.88 | |
| 1life Healthcare Put Put Option | 0.1 | $291k | 8.0k | 36.38 | |
| Zogenix Put Put Option | 0.1 | $221k | 8.2k | 26.95 | |
| Evolus Call Call Option | 0.1 | $198k | 37k | 5.29 |
